Matches in SemOpenAlex for { <https://semopenalex.org/work/W2196316541> ?p ?o ?g. }
- W2196316541 endingPage "28655" @default.
- W2196316541 startingPage "28647" @default.
- W2196316541 abstract "Despite tremendous progress in chemotherapy, drug resistance remains a major challenge for anticancer treatment. The combinations of chemo-photothermal and chemo-chemo treatments have been reported to be potential solutions to overcome drug resistance. In this study, we developed a dual-in-dual synergistic therapy based on the use of dual anticancer drug-loaded graphene oxide (GO) stabilized with poloxamer 188 for generating heat and delivering drugs to kill cancer cells under near-infrared (NIR) laser irradiation. The nanocomparable system is stable and uniform in size, generating sufficient heat to induce cell death. Dual drugs (doxorubicin and irinotecan)-loaded GO (GO-DI) in combination with laser irradiation caused higher cytotoxicity than that caused by the administration of a free single drug as well as a combination of drugs and blank GO in various cancer cells, especially in MDA-MB-231 resistant breast cancer cells. Exposure to hot NIR and GO-DI activated the intrinsic apoptosis pathway, which was confirmed based on changes in the morphology of cell nuclei and overexpression of apoptosis-related proteins. On the basis of the results, the combined treatment showed a synergistic effect compared to the effect of chemotherapy or photothermal treatment alone, demonstrating higher therapeutic efficacy to overcome one of the most severe problem in anticancer therapy, that of intrinsic resistance to chemotherapeutics." @default.
- W2196316541 created "2016-06-24" @default.
- W2196316541 creator A5023049843 @default.
- W2196316541 creator A5026064781 @default.
- W2196316541 creator A5034418015 @default.
- W2196316541 creator A5038396319 @default.
- W2196316541 creator A5054869693 @default.
- W2196316541 creator A5083751923 @default.
- W2196316541 creator A5086090575 @default.
- W2196316541 date "2015-12-17" @default.
- W2196316541 modified "2023-10-17" @default.
- W2196316541 title "Development of a Graphene Oxide Nanocarrier for Dual-Drug Chemo-phototherapy to Overcome Drug Resistance in Cancer" @default.
- W2196316541 cites W1979237215 @default.
- W2196316541 cites W1980377446 @default.
- W2196316541 cites W1986883825 @default.
- W2196316541 cites W1987810093 @default.
- W2196316541 cites W1989573639 @default.
- W2196316541 cites W1991605413 @default.
- W2196316541 cites W1997711971 @default.
- W2196316541 cites W1998526411 @default.
- W2196316541 cites W2007464324 @default.
- W2196316541 cites W2023449605 @default.
- W2196316541 cites W2025132428 @default.
- W2196316541 cites W2028464008 @default.
- W2196316541 cites W2032719882 @default.
- W2196316541 cites W2039555178 @default.
- W2196316541 cites W2049283940 @default.
- W2196316541 cites W2052334189 @default.
- W2196316541 cites W2065355693 @default.
- W2196316541 cites W2075607835 @default.
- W2196316541 cites W2082907765 @default.
- W2196316541 cites W2095509038 @default.
- W2196316541 cites W2102740981 @default.
- W2196316541 cites W2120060289 @default.
- W2196316541 cites W2125292310 @default.
- W2196316541 cites W2126389808 @default.
- W2196316541 cites W2146378598 @default.
- W2196316541 cites W2156980852 @default.
- W2196316541 cites W2160021888 @default.
- W2196316541 cites W2163131115 @default.
- W2196316541 cites W2170874153 @default.
- W2196316541 cites W2317170294 @default.
- W2196316541 cites W2320589001 @default.
- W2196316541 cites W2321849209 @default.
- W2196316541 cites W2328289208 @default.
- W2196316541 cites W2330871576 @default.
- W2196316541 cites W2415825966 @default.
- W2196316541 doi "https://doi.org/10.1021/acsami.5b10426" @default.
- W2196316541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26641922" @default.
- W2196316541 hasPublicationYear "2015" @default.
- W2196316541 type Work @default.
- W2196316541 sameAs 2196316541 @default.
- W2196316541 citedByCount "146" @default.
- W2196316541 countsByYear W21963165412016 @default.
- W2196316541 countsByYear W21963165412017 @default.
- W2196316541 countsByYear W21963165412018 @default.
- W2196316541 countsByYear W21963165412019 @default.
- W2196316541 countsByYear W21963165412020 @default.
- W2196316541 countsByYear W21963165412021 @default.
- W2196316541 countsByYear W21963165412022 @default.
- W2196316541 countsByYear W21963165412023 @default.
- W2196316541 crossrefType "journal-article" @default.
- W2196316541 hasAuthorship W2196316541A5023049843 @default.
- W2196316541 hasAuthorship W2196316541A5026064781 @default.
- W2196316541 hasAuthorship W2196316541A5034418015 @default.
- W2196316541 hasAuthorship W2196316541A5038396319 @default.
- W2196316541 hasAuthorship W2196316541A5054869693 @default.
- W2196316541 hasAuthorship W2196316541A5083751923 @default.
- W2196316541 hasAuthorship W2196316541A5086090575 @default.
- W2196316541 hasConcept C109316439 @default.
- W2196316541 hasConcept C114851261 @default.
- W2196316541 hasConcept C121608353 @default.
- W2196316541 hasConcept C126322002 @default.
- W2196316541 hasConcept C171250308 @default.
- W2196316541 hasConcept C18150654 @default.
- W2196316541 hasConcept C182606246 @default.
- W2196316541 hasConcept C185592680 @default.
- W2196316541 hasConcept C190283241 @default.
- W2196316541 hasConcept C192562407 @default.
- W2196316541 hasConcept C202751555 @default.
- W2196316541 hasConcept C2776694085 @default.
- W2196316541 hasConcept C2779820397 @default.
- W2196316541 hasConcept C2780035454 @default.
- W2196316541 hasConcept C2781303535 @default.
- W2196316541 hasConcept C502942594 @default.
- W2196316541 hasConcept C55493867 @default.
- W2196316541 hasConcept C71924100 @default.
- W2196316541 hasConcept C86803240 @default.
- W2196316541 hasConcept C89423630 @default.
- W2196316541 hasConcept C96232424 @default.
- W2196316541 hasConcept C98274493 @default.
- W2196316541 hasConceptScore W2196316541C109316439 @default.
- W2196316541 hasConceptScore W2196316541C114851261 @default.
- W2196316541 hasConceptScore W2196316541C121608353 @default.
- W2196316541 hasConceptScore W2196316541C126322002 @default.
- W2196316541 hasConceptScore W2196316541C171250308 @default.
- W2196316541 hasConceptScore W2196316541C18150654 @default.
- W2196316541 hasConceptScore W2196316541C182606246 @default.